Interregional research and practical conference with international attendance “Epilepsy and Paroxysmal Conditions as an Interdisciplinary Problem”(19 February 2020)
https://doi.org/10.17749/2070-4909.2020.13.1.88-96
Abstract
The annual Interregional research and practical conference “Epilepsy and Paroxysmal Conditions as an Interdisciplinary Problem” was held in Moscow 19/02/2020, bringing together neurologists and epileptologists from Russia. The event was dedicated to the memory of Gagik N. Avakyan, who was President of Russian League Against Epilepsy (RLAE) for many years. The paper contains key messages of the plenary session.
About the Author
D. A. Petrenko
Sechenov University
Russian Federation
Russian Federation
Daria A. Petrenko – 4th year Student, International school “Medicine of the Future”
8-2 Trubetskaya Str., Moscow 119048
References
1. Recommendations of the Expert Council of the Russian Antiepileptic League on the use of original and reproduced drugs (generics) for the treatment of epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2011; 3 (1): 17–19. (In Russ.)
2. Guidelines for carrying out of routine EEG of neurophysiology expert board of Russian league against epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2016; 8 (4): 99–108. (In Russ.)
3. Resolution of the expert council of the Russian anti-epileptic league regarding the meeting on the rational use of gabapentinoids in epilopthology (24 june, 2017, Moscow). Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (4): 106– 108. (In Russ.)
4. Resolution of the national scientific council of experts “The options of increasing remission in patients with partial epilepsy”. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (3): 73–76. (In Russ.)
5. Karlov V.A., Avakyan G.N., Kalinin V.V., Voronina T.A., Vlasov P.N., Burd S.G., Lipatova L.V., Schneider N.A., Voronkova K.V., Lebedeva A.V., Perunova N.Yu. Opinion of the Expert Council on Epileptology (June 17, 2014). Pseudopharmacoresistance of epilepsy – the current state, problems and solutions. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2015; 7 (1): 69. (In Russ.)
6. Resolution of the meeting of experts of the working group of the Russian Antiepileptic League. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (1): 97–100. (In Russ.)
7. Resolution of the 1st All-Russian Meeting of VNS Therapy Experts. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (3): 298–300. (In Russ.)
8. Resolution of the round table discussion with experts in epilepsy and health ministry executieves (from the Khabarovsk region, the Leningrad region, the Samara region, the Irkutsk region, and the Tyumen region) on the all-russian medical and social project “Attention – Epilepsy!”. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (4): 103–104. (In Russ.)
9. Resolution of the Russian Antiepileptic League expert meeting on treatment of women with epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (2): 195– 199. (In Russ.)
10. Avakyan G.N., Blinov D.V., Lebedeva A.V., Burd S.G., Avakyan G.G. ILAE classification of the epilepsies: the 2017 revision and update. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (1): 6–25. (In Russ.) DOI: https://doi. org/10.17749/2077-8333.2017.9.1.006-025.
11. Avakyan G.N., Blinov D.V., Avakyan G.G., Akarachkova E.S., Burd S.G., Vlasov P.N., Voronkova K.V., Guzeva V.I., Zhidkova I.A., Katunina E.A., Korabelnikov D.I., Lebedeva A.V., Lipatova L.V., Morozova E.A., Oleinikova O.M., Rudakova I.G. Restrictions on the use of valproate in female patients of reproductive age: the updated recommendations based on recent clinical data. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (2): 110–123. (In Russ.) DOI: 10.17749/20778333.2019.11.2.110-123.
12. Avakyan G.N., Blinov D.V., Alikhanov A.A., Perepelova E.M., Perepelov V.A., Burd S.G., Lebedeva A.V., Avakyan G.G. Russian League Against Epilepsy recommendations for the use of structural magnetic resonance imaging in the diagnosis of epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (3): 208–232. (In Russ.) DOI: 10.17749/20778333.2019.11.3.208-232.
13. National Association of Epilepsy Centers. Recommended guidelines for diagnosis and treatment in specialized epilepsy center. Epilepsia. 1990; 31 (1): 1–12.
14. Voronina T.A., Nerobkova L.N., Avakyan G.N., Khromykh E.A., Gaidukov I.O., Avakyan G.G. Search for antiepileptic drugs based on ideas about the mechanisms of formation of the epileptic system. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2013; 5 (4): 29–31.
15. Litvinova S. A., Voronina T. A., Kudrin V. S., Gaydukov I. O., Nerobkova L. N., Pisclova M. B., Avakyan G. G., Zhmurenko L. A. Electrophysiological and neurochemical studies of the mechanisms of the anticonvulsant effect of the new original compound GIZH-298. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2016; 3: 19–26 (In Russ.) DOI: https://doi.org/10.17749/20778333.2016.8.3.019-026.
16. Gaydukov I.O., Litvinova S.A., Voronina T.A., Nerobkova L.N., Zhmurenko L.A., Mokrov G.V., Avakyan G.G., Kutepova I.S. 4-Benzoylpyridine oxime derivative (GIZH-298) versus valproic acid: the anticonvulsant potential effect in a model of epilepsy in rats with cobalt-induced lesions. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (2): 57–66. (In Russ.) DOI: 10.17749/2077-8333.2017.9.2.057-066.
17. Avakyan G.G., Voronina T.A., Nerobkova L.N., Avakyan G.N. Research and development of 2-ethyl-6-methyl-3-oxypyridine succinate nano-form for the treatment of epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2018; 10 (4): 26–38. (In Russ.) DOI: https://doi.org/10.17749/20778333.2018.10.4.026-038.
18. Gekht A.B., Lebedeva A.V., Poletaev A.B. et al. Post-stroke epilepsy. Stroke. 2003; 9: 195. (In Russ.)
19. Lipatova L.V., Dubinina E.E., Alekseeva D.V. The role of oxidative stress in the pathogenesis of epilepsy. Sibirskoye meditsinskoye obozreniye. 2017; 1. (In Russ.)
20. Cardenas-Rodriguez N., Huerta-Gertrudis B., Rivera-Espinoza L. et al. Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models. I Jour Molec Sci. 2013; 14 (1): 14551476.
21. Nerobkova L.N., Avakyan G.G., Voronina T.A., Avakyan G.N. Clinical electroencephalography. Pharmacoelectroencephalography. M. 2018; 281 p. (In Russ.)
22. Badalyan O.L. The effect of the combined use of carbamazepine and antioxidants on the epileptic system (clinical and experimental study). PhD Diss. 1998. (In Russ.)
23. Burd S.G. Features of idiopathic generalized epilepsy in adolescents. PhD Diss. 2002. (In Russ.)
24. Oleinikova O.M. Clinical and neurophysiological features of catamenial epilepsy and secondary amenorrhea. PhD Diss. 2001. (In Russ.)
25. Stoyko M.I. The study of the possibility of using sodium valproate and mexidol and their combination for the treatment and prevention of secondary generalized seizures in epilepsy (clinical and experimental study). PhD Diss. 2002. (In Russ.)
26. Solomatin Yu.V. Search for substances with anticonvulsant activity among derivatives of 3,4-disubstituted benzopyran-2, oximes of 3-benzoylpyridines and carboxylic acid (experimental clinical study). PhD Diss. 2005. (In Russ.)
27. Rider F.K. Inter-gender differences in the functioning of the epileptic system and the effect of lamotrigine (experimental clinical study). PhD Diss. 2005. (In Russ.)
28. Avakyan G.G. Clinical and neurophysiological study of the combination of new forms of anticonvulsants and antioxidants in patients with epilepsy with secondary generalized seizures. PhD Diss. 2011. (In Russ.)
29. Filatova Yu.B. Neurophysiological analysis of the action of topiramate taking into account gender characteristics (experimental clinical study). PhD Diss. 2013. (In Russ.)
30. Arakelyan R.K. Features of the spatial organization of the EEG when using amantadine sulfate in patients with Parkinson’s disease and in the experiment. PhD Diss. 2004. (In Russ.)
31. Malykhina E.A. The study of the functional state of the brain and neuromotor apparatus during antioxidant therapy in Parkinson’s disease (experimental clinical study). PhD Diss. 2006. (In Russ.)
32. Katunina E.A. Pharmacological methods for the correction of motor disorders in Parkinson’s disease (experimental clinical trial). MD Diss. 2011. (In Russ.)
33. Semakina N.V., Mikhailov V.A., Bagaev V.I. Social and psychological characteristics of the quality of life of parents of children with epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2013; 5 (1): 31-37. (In Russ.)
34. Resolution of the russian league against epilepsy workgroup meeting. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2016; 8 (3): 84-85. (In Russ.)
35. Sarzhina M.N., Burd S.G., Mironov M.B., Gunchenko M.M., Batysheva T.T. Continuity of specialized care upon transfer of adolescents with epilepsy from a pediatric to adult outpatient service. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (4): 348-356. (In Russ.) DOI: https://doi.org/10.17749/20778333.2019.11.4.348-356. (In Russ.)
36. Avakyan G.N., Belousova E.D., Burd S.G., Vlasov P.N., Ermolenko N.A., Kissin M.Ya., Lebedeva A.V., Lipatova L.V., Kiteva-Trenchevska G. Current trends in epileptology: priorities, challenges, tasks and solutions. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (4): 395-406. DOI: https://doi. org/10.17749/2077-8333.2019.11.4.395-406. (In Russ.)
37. Guekht A. et al. The epidemiology of epilepsy in the Russian Federation. Epilepsy research. 2010; 92 (2-3): 209-218.
Review
For citations:
Petrenko D.A. Interregional research and practical conference with international attendance “Epilepsy and Paroxysmal Conditions as an Interdisciplinary Problem”(19 February 2020). FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(1):88-96. (In Russ.) https://doi.org/10.17749/2070-4909.2020.13.1.88-96
Views: 681
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 